CTOs on the Move

RapidAI

www.rapidai.com

 
RapidAI is the global leader in using AI to combat life-threatening vascular and neurovascular conditions. From home to hospital and ER to OR, RapidAI is leading the next evolution of clinical decision-making and patient workflow, bringing the end-to-end patient journey into focus. Based on intelligence gained from over 4 million scans in more than 2000 hospitals in over 60 countries, the Rapid® platform transforms care coordination, offering care teams a level of patient visibility never before possible, saving lives, time and money.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Funding

RapidAI raised $25M on 09/17/2020

Similar Companies

Island Hearing

Island Hearing is a Victoria, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ximedica

Ximedica is a full service ISO 13485 certified and FDA registered product development firm with an exclusive focus on medical products. With more than 25 years of experience developing medical devices, combination products and consumer healthcare products our client base spans the globe and ranges from start-ups to the world's largest OEMs.

Northern Illinois Blood Bank

Northern Illinois Blood Bank is a Rockford, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PerforMed Inc

PerforMed Inc is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Neuromod Devices

Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation. We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control of their own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle. Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as ringing in the ears​.